QuantLogix Private Company Profile

← Back to list

Altos Labs

Cellular reprogramming to reverse disease and aging
Biotech 📍 San Francisco, CA Founded 2021
Current Valuation
Private
PRIVATE
Altos Labs is a longevity biotech pursuing cellular rejuvenation programming to restore cell health and resilience. It launched in 2021 with roughly $3B in funding and an all-star scientific roster.

Company Profile

CEO
Hal Barron
Founded
2021
HQ
San Francisco, CA
Total Raised
$3.0B
IPO Status
private

Fundraising Status

privateTotal raised $3.0B

Products

  • Cellular reprogramming / rejuvenation research

Competitors

Retro Biosciences · NewLimit · Calico
BiotechLongevityCellular ReprogrammingDeep Tech
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.